The S&P/ASX Small Ordinaries Index (ASX:XSO) slipped 25.1 points, or 0.74%, to 3,367.6, extending its five-day decline to ...
CorMedix CRMD and Theravance Biopharma TBPH occupy a similar niche in the market as small-cap biopharmaceutical companies working to turn promising science into sustainable revenues. Both companies, ...
In this article, we will look at the 10 Best Small Cap Biotech Stocks to Buy According to Hedge Funds. On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer ...
The S&P/ASX Small Ordinaries Index (ASX: XSO) closed at 3,390.60, down 6.60 points or 0.19% in the latest session. The index has fallen 2.10% over the past five trading days, reflecting ongoing ...
Vir Biotechnology might be on its way to becoming a major player in the market for cancer drugs if Tuesday’s stock reaction is any indication. The San Francisco-based company has been publicly traded ...
Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the questions I get more than any other is, “Jonathan, how do you ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Biotech has reasserted itself over the past year as drug ...
Zacks Investment Research on MSN

Can small-cap stocks continue to outperform?

Small-cap stocks posted a blistering performance in the first half of this year. The Russell 2000 Index surged 22% through June, marking its strongest first-half performance since 1991. It also beat ...